A Study to Evaluate the PK Similarity of AK104 in Healthy Chinese Male Subjects

NCT05559554 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Male Subjects

Interventions

DRUG: AK104 (before the change)
DRUG: AK104 (after the change)

Sponsor

Akeso